-
A New Guideline for Cervical Cancer ScreeningPhysicians Lee Learman and Francisco Garcia discuss the updated U.S. Preventive Services Task Force guideline and the need to increase access to cervical cancer screening.
by Anna Azvolinsky
-
Some Pancreatic Cancers Are HereditaryA trio of recent studies indicates that pancreatic cancer is, in some cases, linked to mutations passed down from generation to generation.
by Cheryl Platzman Weinstock
-
What Is ‘Chemo Brain’?The National Cancer Institute's Todd Horowitz discusses cancer-related cognitive impairment.
by Anna Azvolinsky
-
Predicting Acute Myeloid LeukemiaTwo studies identify genetic mutations that could predict the risk of an aggressive blood cancer up to a decade before it is diagnosed.
by Anna Azvolinsky
-
Healthy Habits
Unhealthy ProcessEating ultraprocessed foods may be linked to an increased risk of certain cancers.
by Kendall Morgan
-
From the Editor-in-Chief
Synthetic Lethality and Cancer: Aiming an Arrow at Achilles’ HeelInsights about synthetic lethality have been used to develop cancer treatments.
by William G. Nelson, MD, PhD
-
Recognizing AI’s PotentialPathologists and radiologists are leading the way in the use of artificial intelligence (AI) to find and track cancer. Machine learning could lay the foundation for using AI more broadly to advance cancer diagnosis and choice of treatment.
by Stephen Ornes
-
Policy Matters
Putting an End to Cancer Health DisparitiesCancer has a disproportionate impact on disadvantaged and minority groups. The AACR 2020 by 2020 initiative is a step toward closing the gap.
by Michael A. Caligiuri, MD
-
Forward Look
From Cold Virus to Cancer FighterNeurosurgeon Frederick F. Lang discusses virus-powered cancer treatments.
by Sue Rochman
-
Forward Look
Opening Clinical Trials to HIV-Positive Cancer PatientsIncluding patients with HIV is part of a larger effort to broaden cancer clinical trial eligibility.
by Andy Kopsa
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
